
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
95,45 | 96,40 | 13:04 | |
95,50 | 96,25 | 21.02. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | Zealand Pharma steadfastly upholds amylin-based obesity drug strategy | ||
Do | Zealand Pharma targets 15-20% weight loss with petrelintide trials in 2025 | ||
Do | Zealand Pharma stock falls loss widens, revenue declines | ||
Do | Zealand Pharma Announces Financial Results for the Full Year 2024 | Company announcement - No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity pipeline... ► Artikel lesen | |
24.01. | Zealand Pharma A/S (OTCMKTS:ZLDPF) Upgraded to Strong-Buy at Cantor Fitzgerald |